Skip to main content
. 2013 Mar 27;5(3):114–119. doi: 10.4254/wjh.v5.i3.114

Table 1.

Patients’ baseline demographics

Patients (n) 35
Female 18/35 (51.4)
Age (yr), mean ± SD 69 ± 13
Tumor type
Cholangiocarcinoma 10/35 (28.5)
Hepatocellular carcinoma 9/35 (25.7)
Pancreatic carcinoma 5/35 (14.3)
Gastric cancer 2/35 (5.7)
Bile duct cancer 2/35 (5.7)
Colorectal cancer 2/35 (5.7)
Gallbladder carcinoma 2/35 (5.7)
Lung cancer 1/35 (2.8)
Breast cancer 1/35 (2.8)
Non-Hodgkin lymphoma 1/35 (2.8)